biomarkers

Podcasts

Patricia K. Coyle, MD, on Fluid and Neurophysiological Biomarkers for the Early Diagnosis of Progression of RRMS to SPMS

08/26/2020

She discusses the current state of evidence on the role of fluid and neurophysiological biomarkers in the early diagnosis of progression of relapsing-remitting MS to secondary progressive MS, and more.

She discusses the current state...

08/26/2020

Neurology

News

Hypercalcemia as a Biomarker for Aggressive Disease in Patients With B-Cell Lymphoma

05/13/2020

For patients with diffuse large B-cell lymphoma (DLBCL), presence of hypercalcemia at diagnosis correlates with negative prognostic factors and a short diagnosis-to-treatment interval, according to a retrospective...

For...

05/13/2020

Journal of Clinical Pathways

Blog

Recognizing The Utility Of Biomarkers In Podiatric Practice And Future Applications

11/12/2019

Barbara J. Aung , DPM, CWS, FAPWHc, CPMA;

Lecturers recently discussed “biomarkers” at the Symposium on Advanced Wound Care Fall (SAWC Fall) 2019 in Las Vegas last month. Attending different lectures, I started to realize that although the term biomarker seems new, biomarkers are...

Lecturers recently discussed...

11/12/2019

Podiatry Today

Research Reports

Patterns of Biomarker Testing Rates and Appropriate Use of Targeted Therapy in the First-Line, Metastatic Non-Small Cell Lung Cancer Treatment Setting

02/15/2018

Michael A. Savin , MD;

Ravi Salgia , MD, PhD;

Blase Polite , MD;

Corey Shamah , MD;

Mark A. Socinski , MD;

Amanda Barry , MPH;

Kathy Lokay ;

Peter G. Ellis , MD;

Casey Mason ;

Ray Page , DO, PhD, FACOI, FASCO;

Natalie Dickson , MD;

Abstract: Despite clear clinical benefit and guideline recommendations for predictive biomarker testing and subsequent first-line targeted therapy treatment in patients with non–small cell lung cancer (NSCLC), there...

...

02/15/2018

Journal of Clinical Pathways

Research in Review

Evidence for Liquid Biopsy Use in Lung Cancer Grows

09/14/2016

JCP Editors

A non-invasive liquid biopsy may be more effective at detecting clinically relevant mutations in patients with advanced lung cancer than standard biopsies, according to a study published in the journal Clinical...

A...

09/14/2016

Journal of Clinical Pathways

Research in Review

Two Biomarkers Predict Treatment Response to Rituximab in RA

09/09/2016

JCP Editors

A 24-week observational study found that a combination of the cellular biomarkers—lymphocyte count (LC) and plasmablast frequency—helps identify patients with rheumatoid arthritis (RA) who will not benefit from...

A...

09/09/2016

Journal of Clinical Pathways

Research in Review

Blood Biomarkers Useful for Understanding NSCLC Prognosis

06/20/2016

JCP Editors

A study of patients with inoperable non-small cell lung cancer (NSCLC) has found that certain blood biomarkers may have prognostic value and could enhance treatment decision-making for providers.  To...

...

06/20/2016

Journal of Clinical Pathways

Research in Review

Personalized Genomic Framework Predicts Treatment Outcomes in AML

12/10/2015

JCP Editors

Researchers have developed a novel prognostic framework using genomic sequencing data to assess risk in patients with acute myeloid leukemia (AML). Their work was presented at the American Society of Hematology (ASH)...

...

12/10/2015

Journal of Clinical Pathways

Research in Review

New Biomarker for Lung Cancer Prognosis Identified

12/08/2015

JCP Editors

New research has identified a biomarker that may help to identify early lung cancer and increase survival. Lung cancer remains the deadliest form of cancer in the United States, killing an estimated 158,000 people a...

New...

12/08/2015

Journal of Clinical Pathways